Invention Grant
- Patent Title: Compounds for use as iron(III) MRI contrast agents
-
Application No.: US16615024Application Date: 2018-05-21
-
Publication No.: US11261208B2Publication Date: 2022-03-01
- Inventor: Janet R. Morrow , Eric M. Snyder , Didar Asik
- Applicant: The Research Foundation for The State University of New York
- Applicant Address: US NY Buffalo
- Assignee: The Research Foundation for The State University of New York
- Current Assignee: The Research Foundation for The State University of New York
- Current Assignee Address: US NY Buffalo
- Agency: Hodgson Russ LLP
- International Application: PCT/US2018/033759 WO 20180521
- International Announcement: WO2018/213853 WO 20181122
- Main IPC: C07F15/02
- IPC: C07F15/02 ; A61K49/08 ; A61K49/10 ; A61K49/12 ; A61K49/14

Abstract:
Provided are macrocyclic compounds and compounds with two or more macrocyclic groups, iron coordinated macrocyclic compounds, and iron coordinated compounds with two or more macrocyclic groups. The iron is high-spin iron(III). The iron coordinated compounds may exhibit a negative redox potential (e.g., relative to a normal hydrogen electrode at a biologically relevant pH, for example, a pH of 6.5-7.5). The compounds can be used as MRI contrast agents.
Public/Granted literature
- US20200079806A1 COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS Public/Granted day:2020-03-12
Information query